Abstract:Congenital heart disease (CHD) is a prevalent condition characterized by defective heart development, causing premature death and stillbirths among infants. Genome-wide association studies (GWASs) have provided insights into the role of genetic variants in CHD pathogenesis through the identification of a comprehensive set of single-nucleotide polymorphisms (SNPs). Notably, 90-95% of these variants reside in the noncoding genome, complicating the understanding of their underlying mechanisms. Here, we developed a systematic computational pipeline for the identification and analysis of CHD-associated SNPs spanning both coding and noncoding regions of the genome. Initially, we curated a thorough dataset of SNPs from GWAS-catalog and ClinVar database and filtered them based on CHD-related traits. Subsequently, these CHD-SNPs were annotated and categorized into noncoding and coding regions based on their location. To study the functional implications of noncoding CHD-SNPs, we cross-validated them with enhancer-specific histone modification marks from developing human heart across 9 Carnegie stages and identified potential cardiac enhancers. This approach led to the identification of 2,056 CHD-associated putative enhancers (CHD-enhancers), 38.9% of them overlapping with known enhancers catalogued in human enhancer disease database. We identified heart-related transcription factor binding sites within these CHD-enhancers, offering insights into the impact of SNPs on TF binding. Conservation analysis further revealed that many of these CHD-enhancers were highly conserved across vertebrates, suggesting their evolutionary significance. Utilizing heart-specific expression quantitative trait loci data, we further identified a subset of 63 CHD-SNPs with regulatory potential distributed across various cardiac tissues. Concurrently, coding CHD-SNPs were represented as a protein interaction network and its subsequent binding energy analysis focused on a pair of proteins within this network, pinpointed a deleterious coding CHD-SNP, , located in C2 domain of protein. Overall, our findings demonstrate that SNPs have the potential to disrupt gene regulatory systems, either by affecting enhancer sequences or modulating protein-protein interactions, which can lead to abnormal developmental processes contributing to CHD pathogenesis.

Identification of Dysfunctional Modules and Disease Genes in Congenital Heart Disease by a Network-Based Approach

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

From Phenotype to Gene: Detecting Disease-Specific Gene Functional Modules Via A Text-Based Human Disease Phenotype Network Construction

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

Towards Prediction and Prioritization of Disease Genes by the Modularity of Human Phenome-Genome Assembled Network.

Pgpm_a_314880 823..837

Systematic Tracking of Disrupted Modules Identifies Altered Pathways Associated with Congenital Heart Defects in Down Syndrome

Systems Analysis of de novo Mutations in Congenital Heart Diseases Identified a Molecular Network in Hypoplastic Left Heart Syndrome

Systems analysis of<i> de</i><i> novo</i> mutations in congenital heart diseases identified a protein network in the hypoplastic left heart syndrome

Identification of susceptible genes for complex chronic diseases based on disease risk functional SNPs and interaction networks

Prioritizing Congenital Heart Disease Genes From Transcriptome And Interactome Via Pagerank

[Research Progress on Genetic and Epigenetic Mechanisms in Congenital Heart Disease].

Abstract 11332: Integration of Protein Interactome Networks with Congenital Heart Disease Variants Reveals Candidate Disease Genes

Disease Gene Discovery of Single-Gene Disorders Based on Complex Network

Screening of Candidate Key Genes Associated with Congenital Heart Disease Using Bioinformatics Data Analysis

A network-based machine-learning framework to identify both functional modules and disease genes

Computational analysis of congenital heart disease associated SNPs: Unveiling their impact on the gene regulatory system

Identification of Key Modules and Hub Genes in Hypertrophic Cardiomyopathy Based on Integrative Weighted Gene Co-expression Network Analysis

Network-based Analysis of Complex Diseases.

Integrative network analysis interweaves the missing links in cardiomyopathy diseasome

An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer.